Details for New Drug Application (NDA): 209929
✉ Email this page to a colleague
The generic ingredient in ASPIRIN AND DIPYRIDAMOLE is aspirin; dipyridamole. There are twenty-two drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the aspirin; dipyridamole profile page.
Summary for 209929
Tradename: | ASPIRIN AND DIPYRIDAMOLE |
Applicant: | Micro Labs |
Ingredient: | aspirin; dipyridamole |
Patents: | 0 |
Pharmacology for NDA: 209929
Mechanism of Action | Cyclooxygenase Inhibitors |
Physiological Effect | Decreased Platelet Aggregation Decreased Prostaglandin Production |
Suppliers and Packaging for NDA: 209929
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ASPIRIN AND DIPYRIDAMOLE | aspirin; dipyridamole | CAPSULE, EXTENDED RELEASE;ORAL | 209929 | ANDA | Micro Labs Limited | 42571-274 | 42571-274-60 | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (42571-274-60) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 25MG;200MG | ||||
Approval Date: | Aug 11, 2021 | TE: | AB | RLD: | No |
Complete Access Available with Subscription